Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vladimir Lj Lazarević"'
Autor:
Mia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Gabriella Glowacki, Christina Orsmark-Pietras, Talía Velasco-Hernández, Vladimir Lj Lazarević, Gunnar Juliusson, Jörg Cammenga, James C. Mulloy, Johan Richter, Thoas Fioretos, Benjamin L. Ebert, Marcus Järås
Publikováno v:
Blood Advances, Vol 1, Iss 23, Pp 2046-2057 (2017)
Abstract: Acute myeloid leukemia (AML) is associated with poor survival, and there is a strong need to identify disease vulnerabilities that might reveal new treatment opportunities. Here, we found that Toll-like receptor 1 (TLR1) and TLR2 are upregu
Externí odkaz:
https://doaj.org/article/71cdb79d494b42dc877ffcc4c6b15024
Autor:
Vladimir Lj Lazarevic, Anders Bredberg, Fryderyk Lorenz, Emma Öhlander, Petar Antunovic, Jörg Cammenga, Lovisa Wennström, Lars Möllgård, Stefan Deneberg, Åsa Derolf, Martin Höglund, Gunnar Juliusson, for the Swedish AML Registry
Publikováno v:
Haematologica, Vol 103, Iss 12 (2018)
Externí odkaz:
https://doaj.org/article/ee3475b786674690b24338781338da22
Autor:
Hareth Nahi, Hans Hägglund, Thomas Ahlgren, Per Bernell, Mats Hardling, Karin Karlsson, Vladimir Lj Lazarevic, Mats Linderholm, Bengt Smedmyr, Maria Åström, Helene Hallböök
Publikováno v:
Haematologica, Vol 93, Iss 11 (2008)
In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with
Externí odkaz:
https://doaj.org/article/12feaa15141a48e7b4472e26b540cca4